polyacrylamide gels, there is a conspicuous DNA species mnigrating just short of marker E. coli 58 RNA. Such a species has also been recently detected in the extracellular ascitic fluid of Ehrlich and NK/Ly tumours of mice, hepatoma 22a, Zajdela hepatoma and ovarian ascites tumours of rats (Beloskhvostov et al., 1976) as well as in ascites fluid in human ovarian tumours (Zelenkova et al. 1980 ). This is not the only nucleic acid species present. Analysis on 1.5% agarose gels revealed larger species, notably a band migrating with a mobility similar to that of mouse mitochondria DNA. Analyses of Krebs 2 extracellular ascitic fluid at various stages of tumour growth indicate that these DNA species are readily visible only at later growth stages, suggesting accumulation in the extracellular fluid (the level at 4 days is about 10% that at 7 days). The extra-20* Accepte(d 28 October 1981 cellular RNA moieties seem to be spread heterogeneously throughout the gels. In view of this high level of nucleic acids detectable in ascites fluid, the question arises concerning their origin and possible biological significance. We do not find these high levels in the blood from normal mice or indeed from mice carrying the tumour.
From preliminary isotope labelling and growth studies carried out in vivo it seems that considerable cell loss occurs during the development of the Krebs 2 tumour. This is similar to the situation during the development of the Ehrlich ascites tumour, where Lala & Patt (1966) found that, although the fraction of cells lost per unit time was constant, the rate of cell loss as a proportion of the rate of cell production rose progressively from 18% on Day 1 to 70o/% on Day 7). Thus tumour-cell loss is a likely cause of the high levels of DNA and RNA fragments in ascitic fluid, the survival of which therein may well be a function of their protection by nucleic-acid-binding proteins. Indeed addition of very high levels of exogenous DNase to ascites fluid (1-2 mg/ml) is required to elicit any further degredation of the DNA in these putative complexes, and metrizamide-gradient analyses indicate a considerable association of the nucleic acid fragments with protein. (Cox & Cocken, 1976 Klein & Revesz, 1953.) Since binding of exogenous DNA to the surface of Ehrlich ascites cells has been reported (Schell, 1968) it was important to ascertain whether bindng of exogenous DNA to Krebs 2 cells also took place. 900 tg Krebs 2 cell [3H]DNA was added to dishes containing 2-day tumour diluted in 3 ml foetal calf serum/ MEM (corresponding to 8 x 105 tumour cells). After 6 h at 37°C the cells were removed and analysed for bound 3H-DNA as described by Schell (1968) . 0.30o of the added DNA bound to the cell surface. Cell-surface-associated DNA on tumorigenic cells has also been reported using anti-tumour platinum-pyrimidine complexes and electron microscopy (Aggarwal el al. 1975) .
We then investigated the ability of cells from 2-day tumours to grow in culture after pretreatment with the high levels of electrophoretically purified DNase I (1 mg/ml) sufficient to digest the DNA of most of the nucleoprotein complexes in the extracellular ascites fluid. This treatment depressed the growth of tumour cells (Fig. lb) . Pretreatment with high levels of RNase A was also effective. It could be however that such unnaturally high levels of nucleases might simply In view of these in vitro data, the effects of exogenous nucleic acids and nucleases on the i.p. growth of the Krebs 2 tumour were assessed, the extent of tumour growth in vivo being measured by relative weight gain (Patt & Blackford, 1954 only PBS), the development of the tumour was enhanced (Fig. 2a) . DNA from mouse or calf thymus was equally effective but E. coli DNA was less so. This stimulatory effect of DNA could be reproduced when the tumour inoculum was reduced to only 4 x 104 tumour cells per mouse (see Fig. 2b ), but RNA administration had a varied and less pronounced stimulatory effect (N.B., naked RNA is more rapidly degraded by ascites fluid than is naked double-stranded DNA). When aliquots of whole tumour were removed from mice and pretreated with DNase (1 mg/ml) or RNase (2 mg/ml) at 37°C for 3 min before inoculation into fresh mice (4 x 107 tumour cells per mouse) there was subsequent gain in body weight but only half the normal. Using smaller tumour inocula, (4 x 104 tumour cells) followed immediately, and also on days 0G'-"a 297 1, 2, 4 and 7 by RNase injection, there was no tumour growth over the next 21 days (Fig. 3a) . If the inoculation with 4 x 104 tumour cells is followed by successive administration of RNase (or DNase) after a delay of 24 h, tumour development (Fig. 3b) is very significantly retarded (more effectively by RNase than by DNase). However, if tumour development after small inocula (4 x 104 tumour cells) is allowed to proceed for 7 days before nuclease treatment, tumour growth is only half.
In these in vivo experiments, RNase was always slightly more effective than DNase. When these nucleases were added directly to aliquots of ascites fluid in vitro and then assayed for activity various times after incubation at 37°C, the activity of RNase remained at its original value, whilst that of DNase always declined to about half its original value after 3 h. Thus DNase is labile in ascites fluid at 37°C, which might explain its lower activity when administered to tumourbearing mice.
It is difficult at this stage to be precise regarding the mechanism of these modulatory effects on Krebs 2 tumour growth, as the reasons for cell loss during growth are not precisely known. One possibility is the random loss of cells termed "apoptosis" (Kerr et at., 1972) . This can occur either because it is an intrinsic property of tumour cells or because of factors in the tumour environment. Whether it can be inhibited by extracellular nucleic acid or nucleoptotein moieties is not known.
It is also likely that some form of cell-mediated toxicity ("natural" or "induced") may be responsible for cell loss. Cytotoxic effector cells are present in both normal and immunodeficient mice, and can lyse a wide range of cells of tumour origin (Heberman & Holden,1978) . Such cells, which are present in significant level without prior priming, and have no immunological memory, may provide an early defence against implanted Krebs 2 cells. As already stressed, non-tumour cells are found amongst the tumour cells at all stages of growth, and we made no attempt to remove them. In later stages some of these non-tumour cells may be involved in induced cell-mediated cytotoxicity. Despite the ease with which the Krebs 2 tumour can be grown in white Porton mice it must still be considered an allograft. Whether, after transplantation, cellular nucleic acid or nucleoprotein fragments released from lysed cells can become associated with intact tumour or lymphocyte cell-surface components to "block" nonspecifically various cytotoxic agents deserves consideration. Indeed such a phenomenon might have implications for transplantation in general. Belokhvostov et al. (1979) have some data to support the possibility that nucleic acid could have a suppressive function. The in vitro and in vivo effects of high levels of nuclease may simply reflect the ability to relieve this nonspecific "blocking" effect by enzymic digestion. Unfortunately, this is insufficient to halt tumour development in vivo if carried out a day or more after tumour implantation. However, prolonged DNase treatment has been successfully used to limit the course of lymphatic leukaemia in AKR mice (Salganik et al., 1967) . On the other hand it should be pointed out that it could simply be that lymphoblasts are more sensitive to the nuclease than are normal cells. This of course may also be true for Krebs 2 cells, but at least our experiments indicate that it is not the case for mouse fibroblasts (L cells).
